Hank Johnson

Hank Johnson

Ask VT AI
View News Summary
  • Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
  • NFL investigates Ravens' handling of Lamar Jackson's injury report, raising scrutiny and potential disciplinary action.
  • Heavyweight title fight ends in no-contest, rematch planned after Aspinall's eye injury
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
  • NFL investigates Ravens' handling of Lamar Jackson's injury report, raising scrutiny and potential disciplinary action.
  • Heavyweight title fight ends in no-contest, rematch planned after Aspinall's eye injury
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Hank Johnson